Bloomberg - Oct. 22 (Bloomberg) -- Roche Holding AG, the world's biggest maker of cancer medicines, won Japanese approval of its Tarceva drug as a treatment for the most common form of lung tumor. Regulators cleared the use of Tarceva in patients with non- small ...
